Dean Erhardt

Mr. Erhardt offers over 30 years of strategic marketing and management experience across both the consumer product and pharmaceutical arenas. Mr. Erhardt’s experience has spanned several Fortune 500 organizations including Express Scripts, Cardinal Health and U.S. Healthcare.

Currently, Mr. Erhardt serves as President & CEO of D2 Solutions. In this capacity he leads the organization in working with a variety of industry stakeholders including pharmaceutical, biotech, medical device and eHealth companies working with channel partners including Pharmacies, Specialty Pharmacies, Specialty Distribution, Retail, Long-Term Care, Hospital/IDNs, Payers and PBMs. As CEO of D2 Solutions, Mr. Erhardt has also worked on various international projects in Albania, Algeria, South Korea and Singapore.

Mr. Erhardt is leading D2 Solutions through a transformation from a traditional consulting organization to a technology-driven organization delivering SaaS solutions to industry stakeholders that drives operational efficiency by reducing the need for human labor, enables better regulatory compliance, and accelerates revenue capture.

Prior to his role at D2, Mr. Erhardt served as Vice President of Sales and Marketing for the Express Scripts Specialty Pharmacy Benefits Management group. In this role, Mr. Erhardt worked with multiple Managed Care and Payer organizations developing formularies, reimbursement models and product support programs for specialty and biotech therapeutic categories. Prior to that position, Mr. Erhardt led Sales and Marketing for Express Scripts Specialty Distribution Services, working with over 30 pharmaceutical manufacturers in the areas of limited distribution programs, Patient Assistance Programs, Sampling, Reimbursement Support, and other product specific support programs.

Mr. Erhardt has a Bachelor of Business Administration in Marketing from the University of Oklahoma and an MBA from the Keller Graduate School of Management. Mr. Erhardt has also participated in numerous executive management training programs. Mr. Erhardt’s Board affiliations have included VirMedica, Inc. and StagesSTL.